GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wanbury Ltd (BOM:524212) » Definitions » Change In Payables And Accrued Expense

Wanbury (BOM:524212) Change In Payables And Accrued Expense : ₹0 Mil (TTM As of Mar. 2025)


View and export this data going back to 1992. Start your Free Trial

What is Wanbury Change In Payables And Accrued Expense?

Wanbury's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was ₹0 Mil. It means Wanbury's Accounts Payable & Accrued Expense stayed the same from Dec. 2024 to Mar. 2025 .

Wanbury's Change In Payables And Accrued Expense for the fiscal year that ended in Mar. 2025 was ₹0 Mil. It means Wanbury's Accounts Payable & Accrued Expense stayed the same from Mar. 2024 to Mar. 2025 .


Wanbury Change In Payables And Accrued Expense Historical Data

The historical data trend for Wanbury's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wanbury Change In Payables And Accrued Expense Chart

Wanbury Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Change In Payables And Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Wanbury Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Wanbury Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wanbury Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Wanbury's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Wanbury Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wanbury Ltd (BOM:524212) » Definitions » Change In Payables And Accrued Expense
Traded in Other Exchanges
Address
BSEL Techpark, B Wing, 10th Floor, Sector 30-A, Opposite Vashi Railway Station, Vashi, Navi Mumbai, MH, IND, 400703
Wanbury Ltd is engaged in the business of pharmaceutical and related activities including research. Some of the company products are Cpink 50mg table, Rabiplus capsules, Folinine softule, etc. The company has one segment of activity namely Pharmaceuticals. It generates revenue from a contract with customers from the sale of manufactured and traded goods. Geographically, key revenue is generated from outside India.

Wanbury Headlines

No Headlines